Videos

Featured

ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
Simplifying Guidelines in Cardio-Kidney-Metabolic Disease

Faiez Zannad

Watch time: 13m 21s
ACC 2025: The ALPACA Phase 2 Trial

Steven E Nissen

Watch time: 2m 54s
THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease

William Herrington

Watch time: 8m 11s

Clara Bonanad Lozano , Anjay Rastogi

Harold Bays, Naveed Sattar, Lydia Alexander, et al

Andrew Frankel, Shelley Zieroth et al

Vijay Chopra, Deepak L Bhatt, George L Bakris, et al

Optimisation of Guideline-directed Medical Therapy in Cardiorenal Patients

Ileana L Piña, David Wheeler, , et al

Watch time: 45m 39s

Trending

Kazem Rahimi, Jordana B Cohen

Watch time: 29m 54s (5 videos)

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
The Rise of CVRM Medicine: Managing Common Co-morbidities as One

Neha Pagidipati, Carel Le Roux, Lawrence A Leiter, et al

Broadcast

Prevention & Chronic Conditions
Assessing the Shift Towards Personalised Medicine – Part 2

Muthiah Vaduganathan, Orly Vardeny et al

Nicolas Girerd

Watch time: 1h 11m 27s (15 videos)
ESC HF 25: The PRAISE-HFrEF Study

Varun Sundaram

Watch time: 4m 10s
HRS 25: The TRANSFORM-AF Study

Varun Sundaram

Watch time: 6m 53s

Broadcast

Prevention & Chronic Conditions
Assessing the Shift Towards Personalised Medicine – Part 1

Jordana B Cohen, Kazem Rahimi

Watch time: 30m 4s

Andrew Frankel, Shelley Zieroth et al

Andrew JS Coats, Stefan Anker

Events

Filter by

Liver Stiffness to Assess Central Venous Pressure in HF

Nicolas Girerd

Watch time: 2m 40s
Kidney Function Trajectories Before and After HF Hospitalisation

Nicolas Girerd

Watch time: 4m 39s
ESC HF 25: The FIVE-STAR Trial

Watch time: 2m 40s
ESCHFA25: FINEARTS-HF: Finerenone Risk-Benefit Across Kidney Function

Safia Chatur

Watch time: 5m 49s
ESC HF 25: The PRAISE-HFrEF Study

Varun Sundaram

Watch time: 4m 10s
Eco 25: The SURMOUNT-1 Study

Luca Busetto

Watch time: 4m 58s
ECO 25: The RESET Trial

Donna H Ryan

Watch time: 8m 25s
HRS 25: The TRANSFORM-AF Study

Varun Sundaram

Watch time: 6m 53s
View from the Thoraxcenter: ACC 25 Wrap Up

Joost Daemen, Nicolas M Van Mieghem

Watch time: 39m 2s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s

Latest

Filter by

Liver Stiffness to Assess Central Venous Pressure in HF

Nicolas Girerd

Watch time: 2m 40s
Kidney Function Trajectories Before and After HF Hospitalisation

Nicolas Girerd

Watch time: 4m 39s
ESC HF 25: The FIVE-STAR Trial

Watch time: 2m 40s
ESCHFA25: FINEARTS-HF: Finerenone Risk-Benefit Across Kidney Function

Safia Chatur

Watch time: 5m 49s

Nicolas Girerd

Watch time: 1h 11m 27s (15 videos)
ESC HF 25: The PRAISE-HFrEF Study

Varun Sundaram

Watch time: 4m 10s
Eco 25: The SURMOUNT-1 Study

Luca Busetto

Watch time: 4m 58s
ECO 25: The RESET Trial

Donna H Ryan

Watch time: 8m 25s